Pharma Reviews: Gujarat FDCA, bioMerieux India train 65 drug inspectors on quality control & microbiological testing

The Gujarat Food and Drug Control Administration (FDCA) and bioMerieux India jointly conducted a training programme recently on pharmaceutical ...
Read more: Gujarat FDCA, bioMerieux India train 65 drug inspectors on quality control & microbiological testing

Pharma Reviews: Govt's drug price caps may trigger showdown with US

On its part, the Indian government — through drug price regulator National Pharmaceutical Pricing Authority (NPPA) — fixes ceiling prices on essential ...
Read more: Govt's drug price caps may trigger showdown with US

Pharma Reviews: 'Encourage performance driven culture'

The pharmaceutical industry in India is facing new challenges as it continues to grow. Keeping this in mind, Ahmedabad University has collaborated ...
Read more: 'Encourage performance driven culture'

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new efforts to advance antimicrobial stewardship in veterinary settings

Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new efforts to advance antimicrobial stewardship in veterinary settings
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on FDA’s new efforts to advance antimicrobial stewardship in veterinary settings

US FDA News: FDA approves first treatment for rare adrenal tumors

FDA approves first treatment for rare adrenal tumors
Read more: FDA approves first treatment for rare adrenal tumors

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to safeguard women’s health from deceptive health claims and significant risks related to devices marketed for use in medical procedures for “vaginal rejuvenation”

FDA warns doctors and patients about deceptive claims on laser medical devices used to treat menopausal symptoms for “vaginal rejuvenation”
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on efforts to safeguard women’s health from deceptive health claims and significant risks related to devices marketed for use in medical procedures for “vaginal rejuvenation”

Pharma Reviews: Indian pharma cos upbeat over US govt move to import select set of pharmaceuticals to check price ...

Indian pharmaceutical manufacturers are upbeat over a move by Washington to explore ways to safely import a select set of drugs from foreign ...
Read more: Indian pharma cos upbeat over US govt move to import select set of pharmaceuticals to check price ...

Pharma Reviews: Indian drug companies eye opportunities in China

According to industry estimates, the market for oncology drugs alone in China is around $17-19 billion. India exports about $17-billion-worth drugs, ...
Read more: Indian drug companies eye opportunities in China

Pharma Reviews: Abbott exits MNC lobby group, may join Indian Pharmaceuticals Alliance

Given the business model for Abbott's pharmaceutical business in India, which focuses on branded generics, not proprietary pharmaceuticals, the ...
Read more: Abbott exits MNC lobby group, may join Indian Pharmaceuticals Alliance

Product Recall Alerts: Tainted high blood pressure, heart failure medications recalled

The Ministry of Health is alerting Jamaicans to the recall of drugs containing the active pharmaceutical ingredient valsartan, which is used to treat high ...
Read more: Tainted high blood pressure, heart failure medications recalled

Product Recall Alerts: Contamination Prompts Voluntary Valsartan Recall

For those prescribed certain drug products containing the active ingredient valsartan, that risk heightened with FDA's July 13 announcement alerting ...
Read more: Contamination Prompts Voluntary Valsartan Recall

Pharma Reviews: Panel recommends ban on 343 fixed dose combination medicines

New Delhi: In a move that could potentially deliver a big blow to pharmaceutical companies in India, an apex advisory board on drugs approved a ...
Read more: Panel recommends ban on 343 fixed dose combination medicines

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on the process FDA is undertaking for reviewing and modernizing the agency’s standards of identity for dairy products

Process FDA is undertaking for reviewing and modernizing the agency’s standards of identity for dairy products
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on the process FDA is undertaking for reviewing and modernizing the agency’s standards of identity for dairy products

Pharma Reviews: USFDA opens door to drug import

This is positive for Indian pharma industry as India is having highest number of USFDA approved drug manufacturing plants outside the US.
Read more: USFDA opens door to drug import

Pharma Reviews: More than 90% of revenues still come from acute therapy business: A Vaidheesh, GSK Pharma

We are getting good support from regulatory bodies for the pharma industry. I see a positive direction for India. Growth to continue in 10-12% range for ...
Read more: More than 90% of revenues still come from acute therapy business: A Vaidheesh, GSK Pharma

Pharma Reviews: FSSAI asks nutraceuticals industry to adopt self-regulation

The industry should clarify the difference between nutraceuticals and ... to make products from equipments and processes designed by pharma industry. ... Indian companies like ITC, Dabur, Himalaya, Patanjali and Baidyanath are ...
Read more: FSSAI asks nutraceuticals industry to adopt self-regulation

Pharma Reviews: Vaccine scandal: Chinese pharma firm chairman arrested, President Xi says its shocking

The authorities found that the company falsified production and inspection records of an anti-rabies vaccine administered to humans and ordered that ...
Read more: Vaccine scandal: Chinese pharma firm chairman arrested, President Xi says its shocking

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on voluntary recalls of Ritz, Goldfish and other products issued out of an abundance of caution

The U.S. Food and Drug Administration is working with Mondelēz International, Inc., Pepperidge Farm Inc. and Flowers Foods, Inc. to initiate voluntarily recalls of certain products due to a potential risk that one of the ingredients may have been contaminated with Salmonella.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on voluntary recalls of Ritz, Goldfish and other products issued out of an abundance of caution

US FDA News: FDA approves magnetic device system for guiding sentinel lymph node biopsies in certain patients with breast cancer

FDA approves magnetic device system for guiding sentinel lymph node biopsies in certain patients with breast cancer
Read more: FDA approves magnetic device system for guiding sentinel lymph node biopsies in certain patients with breast cancer

Pharma Reviews: Pharma hiring may stay muted this year

US pharma company Eli Lilly & Co. India, however, said it will look to fill a majority of its vacancies in India internally. “Between 80-85% of our ...
Read more: Pharma hiring may stay muted this year

US FDA News: FDA continues taking key actions on bulk drug substances used for compounding to advance the regulatory framework governing compounded drugs and to protect patients

FDA continues making progress on bulk drug substances for compounding
Read more: FDA continues taking key actions on bulk drug substances used for compounding to advance the regulatory framework governing compounded drugs and to protect patients

Pharma Reviews: What bear market? We are in a state of consolidation: Rakesh Jhunjhunwala, Rare Enterprises

I think the Indian economy is going into an upturn, capital investment is .... Finally, Indian pharma companies are getting valued on other businesses ...
Read more: What bear market? We are in a state of consolidation: Rakesh Jhunjhunwala, Rare Enterprises

Pharma Reviews: CIPMMA asks govt to consider marketing as separate segment & grant licence for marketers with ...

The UCPMP Code is a voluntary code issued by the Department Of Pharmaceuticals relating to marketing practices for Indian pharmaceutical ...
Read more: CIPMMA asks govt to consider marketing as separate segment & grant licence for marketers with ...

Pharma Reviews: Cos take solace from Indian pharma market

Pharmaceutical companies in India are passing through a gray period as the US Food and Drug Administration (USFDA) is continuing to issue ...
Read more: Cos take solace from Indian pharma market

Pharma Reviews: Blockchain as a health booster

Globally, India's healthcare and pharma sector ranks No. 3, in terms of volume of manufacturing and jobs. The sector is estimated to touch $372 billion ...
Read more: Blockchain as a health booster

Pharma Reviews: USFDA working on plan to import drugs, positive for Indian pharma industry

This we believe is positive for Indian pharma industry as we have highest number of USFDA approved drug manufacturing plants outside the US.
Read more: USFDA working on plan to import drugs, positive for Indian pharma industry

Pharma Reviews: Tamil Nadu has potential to become hub of pharma industries: IDMA

Viewing good future prospects of Indian Pharma sector, he said that the industry is able to produce high quality medicines for the country and also for ...
Read more: Tamil Nadu has potential to become hub of pharma industries: IDMA

Pharma Reviews: Indian Pharma Expo 2018 to be held from August 7 to 9

The three-day expo will bring together eminent personalities from various sectors of pharmaceutical, non-pharma and healthcare industries. IPE 2018 ...
Read more: Indian Pharma Expo 2018 to be held from August 7 to 9

Pharma Reviews: Dr J Vijay Venkatraman to chair 3rd Indian Pharmacovigilance Day conference on July 27 in Mumbai

India is globally recognized as an important hub for generic drug manufacturing and the Indian pharmaceutical industry has carved a niche for itself in ...
Read more: Dr J Vijay Venkatraman to chair 3rd Indian Pharmacovigilance Day conference on July 27 in Mumbai

Pharma Reviews: Tamil Nadu has potential to become a hub of pharma industry like Himachal Pradesh and Gujarat ...

While speaking in a seminar organized by TN IDMA, he said, overall the Indian pharma industry is in a good growth path and has a good future in the ...
Read more: Tamil Nadu has potential to become a hub of pharma industry like Himachal Pradesh and Gujarat ...

Product Recall Alerts: Valsartan Drugs Recalled Over Potential Carcinogen Contamination

Following the EMA, alert, in Europe, Novartis recalled Sandoz' Valsartan and Valsartan HCT film-coated tablets, and drug manufacturers like Dexcel ...
Read more: Valsartan Drugs Recalled Over Potential Carcinogen Contamination

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on manufacturer announcement to halt Essure sales in the U.S.; agency’s continued commitment to postmarket review of Essure and keeping women informed

The FDA responds to Bayer’s announcement to halt Essure sales in the US
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on manufacturer announcement to halt Essure sales in the U.S.; agency’s continued commitment to postmarket review of Essure and keeping women informed

US FDA News: Valsartan-Containing Products: Update Health Professional and Consumer on Recent Recalled Products

The investigation into valsartan-containing products is ongoing and there are currently three voluntary recalls related to the NDMA impurity detected in the valsartan
Read more: Valsartan-Containing Products: Update Health Professional and Consumer on Recent Recalled Products

US FDA News: FDA approves first targeted treatment for patients with relapsed or refractory acute myeloid leukemia who have a certain genetic mutation

FDA approves new drug for the treatment of adults with acute myeloid leukemia who have a specific genetic mutation and a companion diagnostic to detect specific mutations in the IDH1 gene in patients with AML
Read more: FDA approves first targeted treatment for patients with relapsed or refractory acute myeloid leukemia who have a certain genetic mutation

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s efforts to encourage the development of and broaden access to generic versions of opioid analgesics that are formulated to deter abuse

FDA posted a new batch of 43 product-specific guidances related to the development of generic drug products that includes three revised product-specific guidances for ADF opioid products. These guidances recommend specific in vivo studies and in vitro study considerations for abuse deterrence evaluations.
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D., on agency’s efforts to encourage the development of and broaden access to generic versions of opioid analgesics that are formulated to deter abuse

US FDA News: Statement from FDA warning about significant health risks of contaminated illegal synthetic cannabinoid products that are being encountered by FDA

Statement from FDA warning about significant health risks of contaminated illegal synthetic cannabinoid products that are being encountered by FDA
Read more: Statement from FDA warning about significant health risks of contaminated illegal synthetic cannabinoid products that are being encountered by FDA

US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D., on the formation of a new work group to develop focused drug importation policy options to address access challenges related to certain sole-source medicines with limited patient availability, but no blocking patents or exclusivities

FDA forms work group on drug importation policy options to address certain patient access challenges
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., on the formation of a new work group to develop focused drug importation policy options to address access challenges related to certain sole-source medicines with limited patient availability, but no blocking patents or exclusivities

Pharma Reviews: Industry welcomes govt decision to provide Tramadol manufacturers & exporters 4-month ...

Indian pharmaceutical industry has welcomed the Central government's decision to grant four-month exemption to manufacturers and exporters of ...
Read more: Industry welcomes govt decision to provide Tramadol manufacturers & exporters 4-month ...

Pharma Reviews: Post GST, contract pharma manufacturers throng Gujarat

“Apart from new plants, contract manufacturers turning to Gujarat are expected to help the state increase its share in India's pharmaceutical market ...
Read more: Post GST, contract pharma manufacturers throng Gujarat

Pharma Reviews: Indian Pharma: Think beyond mere price control

The fact that the leadership of India's drug price regulator—the National Pharmaceutical Pricing Authority (NPPA)—is almost entirely composed of ...
Read more: Indian Pharma: Think beyond mere price control

Pharma Reviews: Dying to Survive: Indian generic medicines have a tale to tell

Access to low cost generic drugs has been an old argument and Indian pharma companies have often stressed that if given the opportunity they can ...
Read more: Dying to Survive: Indian generic medicines have a tale to tell

Pharma Reviews: India: Evolution Of E-Pharmacies In India – Booming Present, But An Uncertain Future

The reason being that the Indian pharma retail market is valued at approximately INR 1000 billion, with E-pharmacy having the potential to capture a ...
Read more: India: Evolution Of E-Pharmacies In India – Booming Present, But An Uncertain Future

Pharma Reviews: Amazon to invest in Indian Pharma brand MedPlus

The online pharma industry is relatively new in India. But like with other sectors upended by Amazon in the past, offline presence is going to be at the ...
Read more: Amazon to invest in Indian Pharma brand MedPlus

US FDA News: Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for delivery at the Brookings Institution on the release of the FDA’s Biosimilars Action Plan

FDA releases Biosimilars Action Plan to address competition and affordability for biologics and biosimilar products.
Read more: Remarks from FDA Commissioner Scott Gottlieb, M.D., as prepared for delivery at the Brookings Institution on the release of the FDA’s Biosimilars Action Plan

US FDA News: FDA approves first cancer drug through new oncology review pilot that enables greater development efficiency

FDA approves first cancer drug through new oncology review pilot that enables greater development efficiency
Read more: FDA approves first cancer drug through new oncology review pilot that enables greater development efficiency

Product Recall Alerts: FDA recalls blood pressure, heart failure medications after cancer-causing agents found

The DRAP Recall alert stated that a total of nine pharmaceutical companies in Pakistan are on the DRAP recall list and this list does not include Getz ...
Read more: FDA recalls blood pressure, heart failure medications after cancer-causing agents found

US FDA News: New York-based food processors agree to stop food preparation operations due to food safety violations

New York-based food processors agree to stop food preparation operations due to food safety violations
Read more: New York-based food processors agree to stop food preparation operations due to food safety violations

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on new efforts to empower consumers by advancing access to nonprescription drugs

FDA describes innovative approaches to increase access to a broader selection of nonprescription drug products for consumers
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on new efforts to empower consumers by advancing access to nonprescription drugs

Pharma Reviews: Amazon in talks to buy Medplus, India's No. 2 pharmacy chain

The online pharma industry relatively new in India. But like with other sectors upended by Amazon in the past, offline presence is going to be at the ...
Read more: Amazon in talks to buy Medplus, India's No. 2 pharmacy chain

Product Recall Alerts: FDA issues alert on recall of heart drug over 'impurity'

The Food and Drug Administration is alerting health care providers and patients that several versions of a common prescription drug used to treat ...
Read more: FDA issues alert on recall of heart drug over 'impurity'

Product Recall Alerts: Drug Regulatory Authority of Pakistan Recall VALSARTAN

DRAP Recall alert stated that a total of nine Pharmaceuticals Companies in Pakistan are on the DRAP recall list, and this list does not include Getz ...
Read more: Drug Regulatory Authority of Pakistan Recall VALSARTAN

Product Recall Alerts: Drap asks nine firms to recall 'contaminated medicines' used to treat high blood pressure

The directive has been issued after getting an alert from the European Medicating ... Companies have been directed to recall the finished drug containing the ... According to the Drap official, it does not mean that the other products of ...
Read more: Drap asks nine firms to recall 'contaminated medicines' used to treat high blood pressure

Pharma Reviews: Earnings start shifting gears

Coal India is expected to report robust earnings growth led by higher ... In the emerging markets, Indian pharma companies have suffered due to ...
Read more: Earnings start shifting gears

Pharma Reviews: Pharma quality is the key for competition

Therefore, despite the presence of many drug manufacturers in India—which is a pro-competition condition—real competition may not happen as it ...
Read more: Pharma quality is the key for competition

Pharma Reviews: Suboxone saga highlights legal risk in the pharma sector

Indian pharma stocks are in red after US court has ruled against Dr. Reddy's Laboratories on gSuboxone litigation with Indivior. The pharma index was ...
Read more: Suboxone saga highlights legal risk in the pharma sector

Pharma Reviews: Ahmedabad University launches launch Global Executive MBA degree in pharmaceutical ...

Keeping in view this industry requirement, the Ahmedabad University has forayed ... For all the latest Education News, download Indian Express App.
Read more: Ahmedabad University launches launch Global Executive MBA degree in pharmaceutical ...

Product Recall Alerts: FDA Recalls Common Heart Drug for Potential Cancer Risk

A common drug used to treat certain heart conditions is being recalled by the ... The U.S. recall includes drug products containing a version of valsartan ... swift action to alert the public and help facilitate the removal of the products ...
Read more: FDA Recalls Common Heart Drug for Potential Cancer Risk

Pharma Reviews: India, Bahrain make pharma a key area of cooperation

In an important boost to the Indian healthcare industry, India and Bahrain on Sunday agreed to make pharmaceuticals a key area of cooperation ...
Read more: India, Bahrain make pharma a key area of cooperation

Pharma Reviews: Hyderabad airport premises will have pharmaceutical formulation unit soon

With this move, aerospace industry will just constitute 80 acres of the 235.85 acres SEZ; pharmaceutical formulations company will produce tablets, ...
Read more: Hyderabad airport premises will have pharmaceutical formulation unit soon

Product Recall Alerts: FDA Recalls Common Heart Drug Over Potential Cancer Risk

(CNN) — A recall of a common drug used to control blood pressure and ... swift action to alert the public and help facilitate the removal of the products ... They should not discontinue taking medication without a doctor's permission.
Read more: FDA Recalls Common Heart Drug Over Potential Cancer Risk

Product Recall Alerts: FDA Recalls Common Heart Medications Containing Cancer-Causing Forms Of Valsartan

A week after 22 countries recalled drugs used to treat high blood pressure and assist ... CNN reports that the recalled drugs contain forms of the ingredient ... swift action to alert the public and help facilitate the removal of the products ...
Read more: FDA Recalls Common Heart Medications Containing Cancer-Causing Forms Of Valsartan

Product Recall Alerts: FDA joins 22 countries' recall of common heart drug

(CNN) A common drug used to control blood pressure and help prevent heart failure was announced by the US Food and Drug Administration on ...
Read more: FDA joins 22 countries' recall of common heart drug

Product Recall Alerts: FDA joins 22 countries in recall of heart drug

FDA joins 22 countries in recall of heart drug ... to taking swift action to alert the public and help facilitate the removal of the products from the market. As we seek the removal of certain drug products today, our drug shortages team is ...
Read more: FDA joins 22 countries in recall of heart drug

Pharma Reviews: China may ease entry norms for Indian pharma if US trade war hurts

Indian pharmaceutical companies have long been demanding that China quicken its regulatory approvals to allow Indian companies boost exports at ...
Read more: China may ease entry norms for Indian pharma if US trade war hurts

Pharma Reviews: India a key player in generic medicines: Prabhu

Prabhu said that there are great opportunities in African and Latin American countries for Indian pharmaceutical industry andIndia has the potential to ...
Read more: India a key player in generic medicines: Prabhu

Pharma Reviews: Eased norms to help Indian drug firms boost presence in Chinese market; help desk at Chinese ...

The move is expected to bring some cheer to Indian drug manufacturers who are keen on increasing their presence in the Chinese market. According ...
Read more: Eased norms to help Indian drug firms boost presence in Chinese market; help desk at Chinese ...

Pharma Reviews: China opens up to Indian pharma sector amidst looming trade war with US

by Elton Gomes. Amidst an escalating trade war between Beijing and Washington, China has agreed to give swift regulatory approvals to drugs ...
Read more: China opens up to Indian pharma sector amidst looming trade war with US

US FDA News: FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity

FDA is alerting the public about a voluntary recall of several drug products containing valsartan, used to treat high blood pressure and heart failure
Read more: FDA announces voluntary recall of several medicines containing valsartan following detection of an impurity

Pharma Reviews: India to become 6th largest pharma market by 2020: Prabhu

India is likely to be among the top three pharmaceutical markets by incremental growth and sixth largest market globally in absolute size by 2020, ...
Read more: India to become 6th largest pharma market by 2020: Prabhu

Pharma Reviews: Suresh Prabhu asks pharma companies to invest in R&D

Suresh Prabhu asks pharma companies to invest in R&D ... "All companies in pharma industry must ensure that they must invest good part of their ... India is now recognised as a key player globally in the generic medicine industry.
Read more: Suresh Prabhu asks pharma companies to invest in R&D

US FDA News: FDA approves the first drug with an indication for treatment of smallpox

FDA today approved TPOXX (tecovirimat), the first drug with an indication for treatment of smallpox.
Read more: FDA approves the first drug with an indication for treatment of smallpox

Pharma Reviews: Pharma companies must invest in R&D to keep growing: Prabhu

Noting that India is now recognized globally as a key player in the generic medicine industry, Commerce Minister Suresh Prabhu on Friday asked ...
Read more: Pharma companies must invest in R&D to keep growing: Prabhu

Pharma Reviews: Indian Pharma Industry's Revenues Estimated To Have Surged 7.4% In 2017

The Indian pharmaceuticals market witnessed growth at a compound annual growth rate (CAGR) of 5.64%, during 2011 to 2016, with the market ...
Read more: Indian Pharma Industry's Revenues Estimated To Have Surged 7.4% In 2017

Pharma Reviews: Prabhu urged pharma companies to invest in R&D

Pharma sector is main Pillar of Indias manufacturing industry said ... He was addressing at organisation of Pharmaceutical Producers of India.Prabhu ...
Read more: Prabhu urged pharma companies to invest in R&D

Pharma Reviews: Suresh Prabhu asks pharma companies to invest in R&D

While, speaking at the Organisation of Pharmaceutical Producers of India (OPPI) Summit 2018, Suresh Prabhu urged pharma players to invest in a ...
Read more: Suresh Prabhu asks pharma companies to invest in R&D

Pharma Reviews: With US trade under a cloud, China opens to Indian pharma

"The relevant departments have formulated specific measures on promoting China-India pharmaceutical trade cooperation and granting greater ...
Read more: With US trade under a cloud, China opens to Indian pharma

US FDA News: FDA warns of imposters sending consumers fake warning letters

FDA is warning consumers about criminals forging FDA warning letters to target individuals who tried to purchase medicines online or over the phone.
Read more: FDA warns of imposters sending consumers fake warning letters

Pharma Reviews: China crackdown on polluting firms leaves Indian pharma industry in quandary as API prices rise ...

A decisive push by the Chinese government to root out polluting industries across the country is sending shock waves through the Indian ...
Read more: China crackdown on polluting firms leaves Indian pharma industry in quandary as API prices rise ...

Pharma Reviews: Pharma Q1 preview: Poised for strong performance on rebound of domestic and stable US ...

As Indian drug makers brace to report their first-quarter earnings in the days ahead, analysts predict pharmaceutical companies to deliver strong ...
Read more: Pharma Q1 preview: Poised for strong performance on rebound of domestic and stable US ...

Pharma Reviews: With US trade under a cloud, China opens to Indian pharma

“We understand internally that Chinese authorities have issued instructions that EU-approved Indian suppliers should be granted the industrial drug ...
Read more: With US trade under a cloud, China opens to Indian pharma

US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D., on formation of a new drug shortages task force and FDA’s efforts to advance long-term solutions to prevent shortages

FDA Commissioner Scott Gottlieb, M.D., on new drug shortages task force and work towards long-term solutions to prevent shortages
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., on formation of a new drug shortages task force and FDA’s efforts to advance long-term solutions to prevent shortages

US FDA News: FDA expands its support for states to advance implementation of produce safety activities

FDA expands its support for states to advance implementation of produce safety activities
Read more: FDA expands its support for states to advance implementation of produce safety activities

Pharma Reviews: Amid trade war with US, China opens gate to Indian pharma industry: Report

With the trade war between the US and China intensifying with each passing day, the later has decided to open the doors to Indian pharma companies ...
Read more: Amid trade war with US, China opens gate to Indian pharma industry: Report

Pharma Reviews: With United States trade under a cloud, China opens to Indian pharma

No concrete deals have been signed but the outlook for pharmaceutical sales from India is positive, according to officials from both nations.
Read more: With United States trade under a cloud, China opens to Indian pharma

Pharma Reviews: Gujarat FDCA serves notices to pharma companies for remedial measures after concluding joint ...

The move comes at a time when Indian pharma industry is embracing global standards through up-gradation of schedule M units into WHO-GMP units ...
Read more: Gujarat FDCA serves notices to pharma companies for remedial measures after concluding joint ...

Pharma Reviews: Gujarat FDCA concludes joint inspections of 17 MSME manufacturers with CDSCO, serves notices ...

This comes at a time when Indian pharma industry is embracing global standards through upgradation of Schedule M units into WHO -GMP units.
Read more: Gujarat FDCA concludes joint inspections of 17 MSME manufacturers with CDSCO, serves notices ...

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. on agency’s efforts to advance development of gene therapies

Statement from FDA Commissioner Scott Gottlieb, M.D. on agency’s efforts to advance development of gene therapies, including three disease specific draft guidances
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. on agency’s efforts to advance development of gene therapies

Pharma Reviews: Growth challenges in Indian pharma likely to curtail aggregate growth to single digit: ICRA

The growth trajectory for Indian pharmaceutical industry is likely to be moderate, in single digit on the back of slowing growth from US given the ...
Read more: Growth challenges in Indian pharma likely to curtail aggregate growth to single digit: ICRA

Pharma Reviews: As China cancer film hails Indian drugs, New Delhi & Beijing plan big pharma trade push

Indian pharmaceutical firms too have been eager to enter the Chinese market on the back of falling exports to the US, once their biggest buyer.
Read more: As China cancer film hails Indian drugs, New Delhi & Beijing plan big pharma trade push

Pharma Reviews: Pharma sector may post moderate single-digit revenue growth in FY19: ICRA

Pharma sector may post moderate single-digit revenue growth in FY19: ICRA ... “The growth trajectory for Indian pharmaceutical industry is likely to be ...
Read more: Pharma sector may post moderate single-digit revenue growth in FY19: ICRA

Pharma Reviews: TN govt ready to frame Pharmaceutical Industry Policy; offers full support to small & medium ...

Talking about the growth of Indian pharmaceutical industry, Gnanadesikan ... In the case of Tamil Nadu, if a pharma industry policy takes form, it will ...
Read more: TN govt ready to frame Pharmaceutical Industry Policy; offers full support to small & medium ...

Pharma Reviews: India's share of pharma production for exports has tripled since 1985, says senior vice-president of ...

Over 5,000 pharmaceutical companies globally use the manufacturing standards set by the United States Pharmacopeia (USP). USP is an ...
Read more: India's share of pharma production for exports has tripled since 1985, says senior vice-president of ...

US FDA News: Federal judge enters consent decree against Minnesota dairy farm for drug residue violations

Federal judge enters consent decree against Minnesota dairy farm for drug residue violations
Read more: Federal judge enters consent decree against Minnesota dairy farm for drug residue violations

US FDA News: FDA updates warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions

FDA is requiring safety labeling changes for fluoroquinolones to strengthen the warnings about the risks of mental health side effects and serious blood sugar disturbances.
Read more: FDA updates warnings for fluoroquinolone antibiotics on risks of mental health and low blood sugar adverse reactions

US FDA News: Fluoroquinolone Antibiotics: FDA Requires Labeling Changes Due to Low Blood Sugar Levels and Mental Health Side Effects

FDA is strengthening the current warnings in the prescribing information that fluoroquinolone antibiotics may cause significant decreases in blood sugar and certain mental health side effects.
Read more: Fluoroquinolone Antibiotics: FDA Requires Labeling Changes Due to Low Blood Sugar Levels and Mental Health Side Effects

Pharma Reviews: Pharma sector may post single-digit revenue growth in FY19: Report

"The growth trajectory for Indian pharmaceutical industry is likely to be moderate, in single digit, on slowing growth from the US given the relatively ...
Read more: Pharma sector may post single-digit revenue growth in FY19: Report

Pharma Reviews: Sensex breaches 36K-level to end at 6-mn-high of 36239 62 on firm global cues

Sensex breaches 36K-level to end at 6-mn-high of 36,239 62 on firm global ... Persisting growth challenges in Indian pharma sector likely to curtail ...
Read more: Sensex breaches 36K-level to end at 6-mn-high of 36239 62 on firm global cues

Pharma Reviews: Persisting growth challenges in Indian pharma sector likely to curtail aggregate growth to single ...

Mumbai, Jul 10 (UNI) The growth trajectory for Indian pharmaceutical industry is likely to be moderate, in single digit on the back of slowing growth ...
Read more: Persisting growth challenges in Indian pharma sector likely to curtail aggregate growth to single ...

Pharma Reviews: SPDS organises 'Disso India--Hyderabad 2018' to introduce new technology and innovation ...

Society for Pharmaceutical Dissolution Science (SPDS) conducted its 6th Annual International Convention 'Disso India--Hyderabad 2018' on June 28 ...
Read more: SPDS organises 'Disso India--Hyderabad 2018' to introduce new technology and innovation ...

Pharma Reviews: Dragon smiles on Indian pharma industry: Will China's latest move help India bridge wide trade ...

China has recently opened its arms to the Indian pharmaceutical industry, agreeing to reduce tariffs on and increase imports of Indian medicines, ...
Read more: Dragon smiles on Indian pharma industry: Will China's latest move help India bridge wide trade ...

Pharma Reviews: Sensex surges by 231 29 pts

... surged by 231.29 points to 36,166.01 in opening trade on firm Asian cues. ... Persisting growth challenges in Indian pharma sector likely to curtail ...
Read more: Sensex surges by 231 29 pts

Pharma Reviews: Trump healthcare policy not bad for Indian generics, but price may be a worry: Kewal Handa

So, a) he is telling American companies to either charge higher prices to countries outside US and lower the prices in US. b) He is also encouraging ...
Read more: Trump healthcare policy not bad for Indian generics, but price may be a worry: Kewal Handa

Pharma Reviews: Technology, aviation, metals, pharma offer potential for larger India-Russia trade: Denis Manturov

The interest of the new products from India is in the electronics industry. Our Indian partners are strong in programming. If we join forces, we will be ...
Read more: Technology, aviation, metals, pharma offer potential for larger India-Russia trade: Denis Manturov

Pharma Reviews: Indian pharma indicates upward growth across manufacture, QC to warehousing

Another fact is that pharma industry has also witnessed reduced the attrition to around 9 percent from 18 percent a couple of years ago. “It is evident ...
Read more: Indian pharma indicates upward growth across manufacture, QC to warehousing

Pharma Reviews: Aurobindo in last lap to buy Mallinckrodt's US generics business

In May, India's third-largest drug maker Lupin made an impairment provision of Rs 1,400 crore for Gavis Pharma, a company it had bought for $880 ...
Read more: Aurobindo in last lap to buy Mallinckrodt's US generics business

US FDA News: FDA takes action to support American military personnel by granting an authorization for freeze-dried plasma product to enable broader access while the agency works toward approval of the product

FDA granted an EUA to DOD to enable the emergency use of Pathogen-Reduced Leukocyte-Depleted Freeze-Dried Plasma (referred to as French FDP).
Read more: FDA takes action to support American military personnel by granting an authorization for freeze-dried plasma product to enable broader access while the agency works toward approval of the product

Pharma Reviews: Poor Indians turning guinea pigs for greedy pharmaceutical firms

We are notoriously corrupt! People are poor and ignorant also. They do not even try to know. Multinational companies (MNCs) are clever. Doctors are ...
Read more: Poor Indians turning guinea pigs for greedy pharmaceutical firms

Pharma Reviews: Paracetamol sales rising but firms' revenue suffers due to price cuts

Six out of top 10 brands of paracetamol in India — Calpol, Sumo L, P-250, ... The Indian pharma industry earns the majority of its revenue by selling ...
Read more: Paracetamol sales rising but firms' revenue suffers due to price cuts

Pharma Reviews: Misreading the pharma market

India's domestic pharma market sales is about Rs 1.3 lakh crore per year. Less than 11 per cent is under price control. How can the tail wag the dog?
Read more: Misreading the pharma market

Pharma Reviews: Indian drug-makers hit by price erosion in US market

Drug price erosion in the US market, a major export destination for Indian ... Pharma companies are adopting a slew of measures to tackle pricing ...
Read more: Indian drug-makers hit by price erosion in US market

US FDA News: Statement by FDA Commissioner Scott Gottlieb, M.D., on balancing access to appropriate treatment for patients with chronic and end-of-life pain with need to take steps to stem misuse and abuse of opioids

FDA Commissioner statement on balancing access to appropriate treatment for patients with chronic and end-of-life pain with need to take steps to stem opioid misuse and abuse.
Read more: Statement by FDA Commissioner Scott Gottlieb, M.D., on balancing access to appropriate treatment for patients with chronic and end-of-life pain with need to take steps to stem misuse and abuse of opioids

Pharma Reviews: Gujarat FDCA to partner with BV Patel PERD to train drug control officers, pharmacists working in ...

... Indian Pharmaceutical Alliance (IPA) among other industry bodies and companies like Sun Pharma and J B Chemicals to equip drug inspectors and ...
Read more: Gujarat FDCA to partner with BV Patel PERD to train drug control officers, pharmacists working in ...

Pharma Reviews: Gujarat FDCA to collaborate with PERD Centre to train drug regulators on soft skills, analytical ...

Informed Gujarat FDCA Commissioner Dr H G Koshia, “The programme is supported by industry associations like Indian Drug Manufacturers ...
Read more: Gujarat FDCA to collaborate with PERD Centre to train drug regulators on soft skills, analytical ...

Product Recall Alerts: Recalled drugs not in Taiwan

The valsartan was used as an active ingredient in the recalled drugs: Valtensin ... Following an alert by the UK's Medicines and Healthcare Products ...
Read more: Recalled drugs not in Taiwan

Pharma Reviews: Pharma sector may post 17 per cent revenue growth in June quarter: Report

The domestic pharmaceutical sector accounts for 3.1-3.6 per cent of the global pharmaceutical industry in value terms and 10 per cent in volume terms ...
Read more: Pharma sector may post 17 per cent revenue growth in June quarter: Report

Pharma Reviews: High demand of Indian medicines in Philippines

Kolkata, Jul 7 (UNI) The Philippines is in need of Indian medicines as India pharma companies offer standard good quality medicines and equipment ...
Read more: High demand of Indian medicines in Philippines

Product Recall Alerts: Valsartan batches recalled from pharmacies over carcinogenic concerns

The Pharmaceutical Services Negotiating Committee (PSNC) said batches are being recalled as a “precautionary measure” in an alert published on ...
Read more: Valsartan batches recalled from pharmacies over carcinogenic concerns

Product Recall Alerts: Widely taken blood pressure drug valsartan recalled

Widely taken blood pressure drug valsartan recalled ... A Europe-wide alert has gone out after a change in manufacturing process at a Chinese factory ...
Read more: Widely taken blood pressure drug valsartan recalled

Pharma Reviews: A shot of confidence for Indian pharma, its regulator

“I have written to the Health Ministry for India to be a part of PIC/S (Pharmaceutical Inspection Co-operation Scheme),” says Reddy, referring to the ...
Read more: A shot of confidence for Indian pharma, its regulator

Pharma Reviews: Tamil Nadu to come up with new pharma policy; industry welcomes move

He was addressing the industry representatives in Pharmac South, an industry meeting organised by Indian Drug Manufacturers Association (IDMA) in ...
Read more: Tamil Nadu to come up with new pharma policy; industry welcomes move

Pharma Reviews: 4th edition of south Indian pharmaceutical expo 'Pharmac South' to begin in Chennai today

K Gnanadesikan, additional chief secretary in charge of industries department, government of Tamil Nadu, in the presence of Dr. J Radhakrishnan, ...
Read more: 4th edition of south Indian pharmaceutical expo 'Pharmac South' to begin in Chennai today

Pharma Reviews: Pharma companies throng Gujarat to set up new units

Ahmedabad: Gujarat seems poised to regain its lost share in India's pharmaceutical production with firms choosing the state over tax havens for ...
Read more: Pharma companies throng Gujarat to set up new units

Pharma Reviews: Ideal Cures Launches Two New Film Coating Products INSTACOAT QD and INSTACOAT T2F at ...

Ideal Cures, an Indian company headquartered in Mumbai, India, launched two ... India where more than 110 formulators of top India based pharma ...
Read more: Ideal Cures Launches Two New Film Coating Products INSTACOAT QD and INSTACOAT T2F at ...

Pharma Reviews: Pharma exports see double digit growth after a gap of three years

After a gap of three years Indian pharmaceutical exports are seeing a double digit growth in value terms starting this financial year, driven by a surge ...
Read more: Pharma exports see double digit growth after a gap of three years

Pharma Reviews: Shut Chinese companies hit desi pharma players

For the last several decades, the Indian pharmaceutical industry has been dependent on APIs as well as key intermediates for API manufacturing ...
Read more: Shut Chinese companies hit desi pharma players

Pharma Reviews: News digest: NPA mess, pharma mkt, ICICI Pru MF, in-flight calls, and more

If this happens, almost a quarter of the Rs 1.2-trillion Indian pharma market in value terms would come under price control, from around 17 per cent ...
Read more: News digest: NPA mess, pharma mkt, ICICI Pru MF, in-flight calls, and more

US FDA News: Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner for Foods and Veterinary Medicine Steven Ostroff, M.D., on the ongoing risk of salmonella in kratom products

FDA statement on the ongoing risk of salmonella in kratom products
Read more: Statement from FDA Commissioner Scott Gottlieb, M.D. and FDA Deputy Commissioner for Foods and Veterinary Medicine Steven Ostroff, M.D., on the ongoing risk of salmonella in kratom products

Pharma Reviews: Govt aims to boost small pharma firms with 6% interest relief on loans

“I think during this critical transition phase of very strict regulatory compliance when the government expects Indian pharma companies to graduate to ...
Read more: Govt aims to boost small pharma firms with 6% interest relief on loans

Pharma Reviews: Ferring Pharma to set up $250m R&D, manufacturing facility in city

Hyderabad: Swiss pharma giant Ferring Pharmaceuticals will be investing ... This is Ferring's second manufacturing and R&D facility in India after ...
Read more: Ferring Pharma to set up $250m R&D, manufacturing facility in city

Pharma Reviews: No easy cures

On June 28, the National Pharmaceutical Pricing Authority (NPPA) ... However, drug price control measures in India have not always achieved this ...
Read more: No easy cures